期刊文献+

温阳除痹汤对硬皮病模型小鼠皮肤结缔组织生长因子及Ⅰ型胶原蛋白表达的影响 被引量:10

Effects of Wenyang Chubi Decoction on connective tissue growth factor and collagen-Ⅰin a mouse model of scleroderma
下载PDF
导出
摘要 目的:研究温阳除痹汤对硬皮病小鼠结缔组织生长因子(connective tissue growth factor,CTGF)、Ⅰ型胶原蛋白(collagen-Ⅰ,COL-Ⅰ)表达的影响。方法:将博来霉素诱导的硬皮病小鼠随机分为3组:模型组、生理盐水组和温阳除痹汤组,以正常BALB/c小鼠作为对照。生理盐水组和温阳除痹汤组分别灌服生理盐水和温阳除痹汤,连续给药1个月。观察皮肤和肺组织病理学变化,并采用免疫组化技术检测各组硬皮病小鼠皮损中CTGF和COL-Ⅰ蛋白含量。结果:造模组小鼠皮肤CTGF和COL-Ⅰ免疫组化指数较对照组明显增加,差异有统计学意义(P<0.05)。与灌服生理盐水的模型小鼠比较,温阳除痹汤组小鼠皮肤和肺组织学有明显改善(P<0.05);温阳除痹汤组CTGF及COL-Ⅰ蛋白含量较生理盐水组亦显著降低,差异有统计学意义(P<0.05)。结论:CTGF及COL-1在硬皮病小鼠皮肤组织中具有较高表达,温阳除痹汤可明显降低CTGF、COL-Ⅰ含量,改善皮肤硬化。 Objective: To study the effects of Wenyang Chubi Decoction (WYCBD), a compound traditional Chinese herbal medicine, on connective tissue growth factor (CTGF) and collagen-Ⅰ (COL-Ⅰ ) in a mouse model of scleroderma. Methods: Scleroderma was induced in BALB/c mice by daily local injection of bleomycin for three weeks and the mice were randomly divided into untreated, WYCBD-treated and normal saline (NS) treated groups, with another group of BALB/c mice as normal control. WYCBD and NS were given orally for one month respectively. Histopathology in the skin and lungs of the mice were examined. The CTGF and COL-Ⅰ expressions in the skin or skin lesions were detected by immunohistochemical Elivision assay. Results : The expression levels of CTGF and COL- Ⅰ in the untreated group were significantly higher than those in the normal control group (P〈0.05). Compared with the NS-treated group, the WYCBD-treated group had significant improvement in the skin and lung histopathology and remarkably decreased expression levels of CTGF and COL- Ⅰ (P〈0. 05). Conclusion: Scleroderma mice showed high expressions of CTGF and COL-Ⅰ in the skin. WYCBD had the effects of decreasing the CTGF and COL- Ⅰ expressions and improving the skin fibrosis.
出处 《中西医结合学报》 CAS 2007年第5期526-530,共5页 Journal of Chinese Integrative Medicine
关键词 硬皮病 中草药 实验动物模型 结缔组织 生长因子 胶原Ⅰ型 小鼠 scleroderma drugs, Chinese herbal experimental animal models bleomycin connective tissue growth factors collagen type Ⅰ mice
  • 相关文献

参考文献12

  • 1Yamamoto T,Takagawa S,Katayama I,et al.Animal model of sclerotic skin.Ⅰ:Local injections of bleomycin induce sclerotic skin mimicking scleroderma.J Invest Dermatol.1999;112(4):456-462.
  • 2朱鹭冰,李明.博来霉素诱导硬皮病小鼠模型及其抗体测定的初步研究[J].中华皮肤科杂志,2003,36(9):496-498. 被引量:15
  • 3屠文震,赵凯,陆磊.建立硬皮病小鼠模型的实验研究[J].中华风湿病学杂志,2003,7(8):478-481. 被引量:12
  • 4章元沛.药理学实验(第2版)[M].北京:人民卫生出版社,1996.68.
  • 5Bradham DM,Igarashi A,Potter RL,et al.Connective tissue growth factor:a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10.J Cell Biot.1991;114(6):1285-1294.
  • 6Igarashi A,Nashiro K,Kikuchi K,et al.Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis.J Invest Dermatol.1995;105(2):280-284.
  • 7Querfeld C,Eckes B,Huerkamp C,et al.Expression of TGF-beta 1,-beta 2 and-beta 3 in localized and systemic scleroderma.J Dermatol Sci.1999;21(1):13-22.
  • 8Margotta V,Capogreco M.Soft tissue pathologies of the oral cavity.Minerva Stomatol.2003;52(1-2):47-51.
  • 9Pasco S,Ramont L,Maquart FX,et al.Biological effects of collagen Ⅰ and Ⅳ peptides.J Soc Biol.2003;197(1):31-39.
  • 10Stumpf M,Cao W,Klinge U,et al.Collagen distribution and expression of matrix metalloproteinases 1 and 13 in patients with anastomotic leakage after largebowel surgery.Langenbecks Arch Surg.2002;386(7):502-506.

二级参考文献20

  • 1秦慧莲 匡彦德.四甲基偶氮唑盐比色法测定白细胞介素-2活性及淋巴细胞增殖反应[J].上海医科大学学报,1987,14(6):407-407.
  • 2Yamamoto T, Takagawa S, Katayama I, et al. Animal model of sclerotic skin. I. Local injections of bleomycin induce sclerotic skin mimicking scleroderma. J Invest Dermatol,1999,112:456-462.
  • 3Judy VD, Gershwin ME. An inherited fibrotic disease of white Leghorn chickens resembling progressive systemic sclerosis. Am J Pathol, 1985,120 : 478-482.
  • 4Bennett JP, Burns CP. Absence of progress of recurrent bleomycin skin toxicity without postponement or attenuation of therapy. Am J Medicine, 1988,85 : 585-586.
  • 5Yamamoto T, Katayama I, Nishioka K. Fibroblast proliferation by bleomycin stimulated perpheral blood mononuclear cell factors. J Rheumatol, 1999,26 : 609-615.
  • 6Oder WA, Noble NA. Transforming growth factor β in tissue fibrosis. New Engl J Med, 1994,331 : 1286-1292.
  • 7Karukonda SR, Flynn TC, Boh EE, et al. The effects of drugs on wound healing: part 1. Int J Dermatol, 2000,39 : 250-257.
  • 8Higley H, Persichitte S, Chu S, et al. Immunocytochemical localization and serologic detection of transforming growth factor beta-1:association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon. Arthritis Rheum, 1994,37:278-288.
  • 9Kissin EY, Lemaire R, Kom JH, et al. Transforming growth factor beta induces fibroblast fibrillin-1 matrix formation. Arthritis Rheum, 2002,46 : 3000-3009.
  • 10Yamamoto T, Takagama S, Katayama I, et al. Anti-sclerotic effect of transforming growth factor-beta antibody in a mouse model of bleomycin-induced scleroderma. J Clin Immunol, 1999,92 : 6-13.

共引文献39

同被引文献117

引证文献10

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部